Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

International Journal of Cancer. Journal International Du Cancer
Igor P PogribnyOlga Kovalchuk

Abstract

Cancer cells that develop resistance to chemotherapeutic agents are a major clinical obstacle in the successful treatment of breast cancer. Acquired cancer chemoresistance is a multifactorial phenomenon, involving various mechanisms and processes. Recent studies suggest that chemoresistance may be linked to drug-induced dysregulation of microRNA function. Furthermore, mounting evidence indicates the existence of similarities between drug-resistant and metastatic cancer cells in terms of resistance to apoptosis and enhanced invasiveness. We studied the role of miRNA alterations in the acquisition of cisplatin-resistant phenotype in MCF-7 human breast adenocarcinoma cells. We identified a total of 103 miRNAs that were overexpressed or underexpressed (46 upregulated and 57 downregulated) in MCF-7 cells resistant to cisplatin. These differentially expressed miRNAs are involved in the control of cell signaling, cell survival, DNA methylation and invasiveness. The most significantly dysregulated miRNAs were miR-146a, miR-10a, miR-221/222, miR-345, miR-200b and miR-200c. Furthermore, we demonstrated that miR-345 and miR-7 target the human multidrug resistance-associated protein 1. These results suggest that dysregulated miRNA expressi...Continue Reading

References

Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Sep 2, 1999·Biochemical and Biophysical Research Communications·I PogribnyS J James
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 22, 2002·Current Cancer Drug Targets·Y LiangMartin Clynes
Dec 17, 2002·Cancer Treatment and Research·Zahid H Siddik
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Aug 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Konstantin D TaganovDavid Baltimore
Aug 22, 2006·Current Cancer Drug Targets·L O'Driscoll, M Clynes
Nov 17, 2006·Nucleic Acids Research·Molly MegrawArtemis G Hatzigeorgiou
Mar 14, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Tito Fojo
May 18, 2007·Nature Reviews. Cancer·Héctor PeinadoAmparo Cano
Jun 15, 2007·Journal of Mammary Gland Biology and Neoplasia·Georgia AgiostratidouRachel B Hazan
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Sep 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Muller FabbriCarlo M Croce
Oct 11, 2007·Drug News & Perspectives·Ernest K J PauwelsCélia M F Gomes
Nov 10, 2007·Nucleic Acids Research·Sam Griffiths-JonesAnton J Enright
Nov 13, 2007·Advances in Experimental Medicine and Biology·Ana Maria Gonzalez-AnguloGabriel N Hortobagyi
Nov 13, 2007·Nature Neuroscience·Matthew E KleinRichard H Goodman
Jan 12, 2008·Molecular Cancer Therapeutics·Paul E BlowerWolfgang Sadee
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 1, 2008·Breast Cancer Research : BCR·Massimo Negrini, George Adrian Calin
Apr 5, 2008·JAMA : the Journal of the American Medical Association·Chaitanya R AcharyaAnil Potti
Jul 23, 2008·Molecular Cancer Therapeutics·Olga KovalchukIgor P Pogribny
Jul 31, 2008·British Journal of Cancer·S Raguz, E Yagüe
Aug 19, 2008·The Journal of Biological Chemistry·Tyler E MillerSarmila Majumder
Oct 7, 2008·TheScientificWorldJournal·Emily L PatersonGregory J Goodall
Oct 17, 2008·Molecular Cell·Motozo YamashitaYing E Zhang

❮ Previous
Next ❯

Citations

Aug 29, 2012·Cellular and Molecular Life Sciences : CMLS·Huiping Liu
May 7, 2013·Cancer Chemotherapy and Pharmacology·Jie WangZhong-ping Chen
Feb 22, 2012·Journal of Mammary Gland Biology and Neoplasia·Erin N HoweJennifer K Richer
Oct 5, 2011·Pharmaceutical Research·Ding-Wu Shen, Michael M Gottesman
Aug 24, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Wei TianYongchuan Deng
May 18, 2011·Molecular Cancer·Matthias PortMichael Abend
Sep 8, 2012·BMC Medical Genomics·Iver NordentoftLars Dyrskjøt
Sep 17, 2013·PloS One·Irina SurguchevaAndrei Surguchov
Mar 19, 2014·PloS One·Luis G Pérez-RivasJosé Lozano
Aug 28, 2012·Epigenomics·Sierk Haenisch, Ingolf Cascorbi
Nov 23, 2013·Cancer Letters·Xiangling FengYaguang Xi
Feb 5, 2013·Briefings in Bioinformatics·Jakob Lewin RukovNoam Shomron
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jianxin LvHui Xie
Sep 20, 2011·Radiation and Environmental Biophysics·Jennifer S DickeyOlga Kovalchuk
Apr 6, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bailong LiBo Song
Dec 2, 2014·Expert Opinion on Therapeutic Targets·Dian-Na GuLing Tian
Aug 27, 2015·Journal of Clinical Medicine·Jessica L HorshamPeter J Leedman
Sep 6, 2014·Expert Opinion on Biological Therapy·Giulia BottaiLibero Santarpia
Apr 10, 2013·Expert Opinion on Drug Metabolism & Toxicology·Igor P Pogribny, Frederick A Beland
Nov 7, 2015·Drug Metabolism Reviews·Jamie F LuMary Bebawy
Mar 23, 2012·Expert Opinion on Drug Metabolism & Toxicology·Igor KoturbashIgor P Pogribny
Apr 19, 2011·Toxicology Mechanisms and Methods·Curtis D KlaassenJulia Yue Cui
Jan 13, 2016·International Journal of Cancer. Journal International Du Cancer·Máire-Caitlín CaseyMichael J Kerin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.